Literature DB >> 28413988

Cognitive Mechanisms in Decision-Making in Patients With Mild Alzheimer Disease.

Jose Ramon Alameda-Bailen1, Maria Pilar Salguero-Alcaniz2, Ana Merchan-Clavellino2, Susana Paino-Quesada3.   

Abstract

BACKGROUND: Alzheimer's dementia is characterized by significant cortical and subcortical atrophy, causing diverse neuropsychological deficits. According to the somatic marker hypothesis, the areas responsible for generating the somatic markers that anticipate the consequences of a decision and thereby optimize the process would be affected in these patients.
OBJECTIVE: The aim of this experiment is to study the decision-making processes in Alzheimer type dementia patients to determine potential deficits in these processes as a result of the disease, aside from the cognitive impairment that is typical of aging. In addition, we wish to determine the defining characteristics of decision-making in these patients, on the basis of the prospect valence-learning parameters.
METHOD: We evaluated 30 patients with Alzheimer's disease and a control group of 30 healthy subjects. A short version of the Iowa Gambling Task was used.
RESULTS: The results showed that patients made less advantageous choices than did controls. Group differences were quantitative and qualitative, as significant differences in cognitive mechanisms identified in the prospect valence-learning decisions were observed. These results are consistent with evidence from neuroimaging studies as well as with work carried out with amnesic patients.
CONCLUSION: That problems in our patients' decision-making could be due to the characteristic memory deficits of this disease, which prevents them from establishing new stimulus-reward relationships and eliminating previously learned responses as a result of the parietal and temporal atrophy they present. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Mild alzheimer dementia; decision making; memory loss.; prospect valence learning; software carts; somatic marker hypothesis

Mesh:

Year:  2017        PMID: 28413988     DOI: 10.2174/1567205014666170417113834

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  7 in total

Review 1.  Decision-Making Competence in Patients with Alzheimer's Disease: A Review of the Literature.

Authors:  Fanny Gaubert; Hanna Chainay
Journal:  Neuropsychol Rev       Date:  2021-02-12       Impact factor: 7.444

Review 2.  How does decisional capacity evolve with normal cognitive aging: systematic review of the literature.

Authors:  Thomas Tannou; Séverine Koeberlé; Régis Aubry; Emmanuel Haffen
Journal:  Eur Geriatr Med       Date:  2019-10-12       Impact factor: 1.710

3.  Manual Dexterity and Aging: A Pilot Study Disentangling Sensorimotor From Cognitive Decline.

Authors:  Loic Carment; Abir Abdellatif; Carmelo Lafuente-Lafuente; Sylvie Pariel; Marc A Maier; Joël Belmin; Påvel G Lindberg
Journal:  Front Neurol       Date:  2018-10-29       Impact factor: 4.003

4.  Age of onset of cannabis use and decision making under uncertainty.

Authors:  Pilar Salguero-Alcañiz; Ana Merchán-Clavellino; Susana Paíno-Quesada; Jose Ramón Alameda-Bailén
Journal:  PeerJ       Date:  2018-07-03       Impact factor: 2.984

5.  Decision-Making Under Ambiguity or Risk in Individuals With Alzheimer's Disease and Mild Cognitive Impairment.

Authors:  Tingting Sun; Teng Xie; Jing Wang; Long Zhang; Yanghua Tian; Kai Wang; Xin Yu; Huali Wang
Journal:  Front Psychiatry       Date:  2020-03-18       Impact factor: 4.157

6.  Decision Making Profile of Positive and Negative Anticipatory Skin Conductance Responders in an Unlimited-Time Version of the IGT.

Authors:  Ana Merchán-Clavellino; María P Salguero-Alcañiz; Fernando Barbosa; Jose R Alameda-Bailén
Journal:  Front Psychol       Date:  2019-10-15

7.  The Impact of Compulsivity and Impulsivity in Cerebellar Ataxia: A Case Series.

Authors:  Nadia Amokrane; Chi-Ying R Lin; Natasha A Desai; Sheng-Han Kuo
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-10-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.